Pacific Biosciences of California, Inc. (PACB)
1.96
-0.03
(-1.51%)
USD |
NASDAQ |
Oct 15, 16:00
1.97
+0.01
(+0.51%)
After-Hours: 20:00
Pacific Biosciences of California Cash from Operations (TTM) : -118.05M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -118.05M |
| March 31, 2026 | -111.84M |
| December 31, 2025 | -111.21M |
| September 30, 2025 | -122.79M |
| June 30, 2025 | -149.55M |
| March 31, 2025 | -174.43M |
| December 31, 2024 | -206.06M |
| September 30, 2024 | -233.02M |
| June 30, 2024 | -253.22M |
| March 31, 2024 | -247.54M |
| December 31, 2023 | -266.55M |
| September 30, 2023 | -269.50M |
| June 30, 2023 | -266.89M |
| March 31, 2023 | -278.87M |
| December 31, 2022 | -263.21M |
| September 30, 2022 | -234.35M |
| June 30, 2022 | -211.96M |
| March 31, 2022 | -167.10M |
| December 31, 2021 | -111.18M |
| September 30, 2021 | -93.74M |
| June 30, 2021 | -70.89M |
| March 31, 2021 | -78.96M |
| December 31, 2020 | 19.50M |
| September 30, 2020 | 15.59M |
| June 30, 2020 | 16.13M |
| Date | Value |
|---|---|
| March 31, 2020 | 22.36M |
| December 31, 2019 | -78.31M |
| September 30, 2019 | -79.12M |
| June 30, 2019 | -76.03M |
| March 31, 2019 | -72.97M |
| December 31, 2018 | -66.43M |
| September 30, 2018 | -67.64M |
| June 30, 2018 | -71.31M |
| March 31, 2018 | -69.62M |
| December 31, 2017 | -67.52M |
| September 30, 2017 | -60.22M |
| June 30, 2017 | -58.26M |
| March 31, 2017 | -64.33M |
| December 31, 2016 | -67.93M |
| September 30, 2016 | -55.74M |
| June 30, 2016 | -55.64M |
| March 31, 2016 | -44.24M |
| December 31, 2015 | -47.89M |
| September 30, 2015 | -62.53M |
| June 30, 2015 | -53.00M |
| March 31, 2015 | -59.12M |
| December 31, 2014 | -51.47M |
| September 30, 2014 | -50.68M |
| June 30, 2014 | -25.73M |
| March 31, 2014 | -28.51M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Illumina, Inc. | 1.095B |
| Danaher Corp. | 6.635B |
| Thermo Fisher Scientific, Inc. | 9.013B |
| Agilent Technologies, Inc. | 1.609B |
| Bio-Rad Laboratories, Inc. | 492.60M |